Literature DB >> 24743723

Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interaction.

Gudrun Hefner1, Katharina Geschke, Christoph Hiemke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24743723     DOI： 10.1097/JCP.0000000000000127

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN： 0271-0749            Impact factor:   3.153


× No keyword cloud information.
  1 in total

1.  Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey.

Authors:  Gudrun Hefner; Stefan Unterecker; Mohamed E E Shams; Margarete Wolf; Tanja Falter; Ekkehard Haen; Christoph Hiemke
Journal:  J Neural Transm (Vienna)       Date:  2015-05-05       Impact factor: 3.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.